These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 7845680)

  • 1. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
    Huen DS; Henderson SA; Croom-Carter D; Rowe M
    Oncogene; 1995 Feb; 10(3):549-60. PubMed ID: 7845680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions.
    Floettmann JE; Eliopoulos AG; Jones M; Young LS; Rowe M
    Oncogene; 1998 Nov; 17(18):2383-92. PubMed ID: 9811470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Construction and function analysis of a CTAR-2 region mutant of the Epstein-Barr virus-encoded latent membrane protein-1].
    He ZM; Chen ZC
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):261-5. PubMed ID: 12621551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.
    Mainou BA; Everly DN; Raab-Traub N
    Oncogene; 2005 Oct; 24(46):6917-24. PubMed ID: 16007144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
    Eliopoulos AG; Young LS
    Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain.
    Coffin WF; Erickson KD; Hoedt-Miller M; Martin JM
    Oncogene; 2001 Aug; 20(38):5313-30. PubMed ID: 11536044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
    Miller WE; Cheshire JL; Baldwin AS; Raab-Traub N
    Oncogene; 1998 Apr; 16(14):1869-77. PubMed ID: 9583684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
    Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y
    Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
    Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
    Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.
    Wakisaka N; Murono S; Yoshizaki T; Furukawa M; Pagano JS
    Cancer Res; 2002 Nov; 62(21):6337-44. PubMed ID: 12414666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
    Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1.
    Henriquez NV; Floettmann E; Salmon M; Rowe M; Rickinson AB
    J Immunol; 1999 Mar; 162(6):3298-307. PubMed ID: 10092782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
    Nitta T; Chiba A; Yamamoto N; Yamaoka S
    Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of NF-kappa B activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases.
    Wu CJ; Leu CY; Liu ST; Chow KP; Meng CL; Chang YS
    Gene Ther; 1998 Jul; 5(7):905-12. PubMed ID: 9813661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.
    Hatzivassiliou E; Miller WE; Raab-Traub N; Kieff E; Mosialos G
    J Immunol; 1998 Feb; 160(3):1116-21. PubMed ID: 9570524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
    Floettmann JE; Ward K; Rickinson AB; Rowe M
    Virology; 1996 Sep; 223(1):29-40. PubMed ID: 8806537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
    Dirmeier U; Neuhierl B; Kilger E; Reisbach G; Sandberg ML; Hammerschmidt W
    Cancer Res; 2003 Jun; 63(11):2982-9. PubMed ID: 12782607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.